DelveInsight’s “Bipolar Disorder Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Bipolar Disorder market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
The report covers emerging Bipolar Disorder drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Bipolar Disorder treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Bipolar Disorder: An Overview
Bipolar Disorder (formerly called manic-depressive illness or manic depression, is a mental disorder that causes unusual shifts in mood, energy, activity levels, concentration, and the ability to carry out day-to-day tasks. It is a condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression). When the mood of a person shifts to mania or hypomania (less extreme than mania), the person may feel euphoric, full of energy, or unusually irritable. These mood swings can affect sleep, energy, activity, judgment, behavior, and the ability to think clearly.
There are three types of bipolar disorder. All three types involve clear changes in mood, energy, and activity levels. These moods range from periods of extremely “up,” elated, irritable, or energized behavior (known as manic episodes) to very “down,” sad, indifferent, or hopeless periods (known as depressive episodes). Three different types of bipolar disorder include Bipolar I Disorder, Bipolar II Disorder, and Cyclothymic Disorder (also called Cyclothymia). Sometimes a person might experience symptoms of bipolar disorder that do not match the three categories, which are referred to as “other specified and unspecified bipolar and related disorders.”
Bipolar Disorder Market Key Facts
-
In the year 2020, the total diagnosed prevalent cases of Bipolar Disorder (Manic Depression) was 3,552,000+ cases in the 7MM which is expected to grow by 2032.
-
In the United States, the total number of diagnosed prevalent cases of Bipolar Disorder (Manic Depression) was 2,401,000+ cases in the year 2020.
-
In the year 2020, the total diagnosed prevalent cases of Bipolar Disorder (Manic Depression) were 1,004,000+ cases in EU-5.
-
In Japan, the total number of diagnosed prevalent cases of Bipolar Disorder (Manic Depression) was 146,621 cases in the year 2020.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Bipolar Disorder pipeline therapies. It also thoroughly assesses the Bipolar Disorder market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete details of the market trend for each marketed Bipolar Disorder drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MOA), Route of Administration (ROA), molecule types, competition with other therapies, brand value, and their impact on the market.
Bipolar Disorder Epidemiology Assessment
The epidemiology section provides insights into the historical, current, and forecasted Bipolar Disorder epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted Bipolar Disorder epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pools, future trends, and views of key opinion leaders.
The Report Covers the Bipolar Disorder Epidemiology, Segmented as –
-
Total Prevalent Cases of Bipolar Disorder in the 7MM [2019–2032]
-
Bipolar Disorder cases by age group in the 7MM [2019–2032]
-
Total diagnosed cases of Bipolar Disorder in 7MM [2019–2032]
-
Type-specific cases of Bipolar Disorder in the 7MM [2019–2032]
-
Treated cases of Bipolar Disorder in the 7MM [2019–2032]
Bipolar Disorder Drugs Uptake and Pipeline Development Activities
The drug uptake section focuses on the uptake rate of potential drugs recently launched in the Bipolar Disorder market or expected to be launched during the study period. The analysis covers the Bipolar Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the market dynamics by drug sales, the most rapid drug uptake, and the reasons behind the maximal use of particular drugs. Additionally, it compares the Bipolar Disorder drugs based on their sale and market share.
The report also covers the Bipolar Disorder pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key Bipolar Disorder companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn How the Bipolar Disorder Market Will Evolve and Grow by 2032 @
https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market-insight
Bipolar Disorder Therapeutics Analysis
There are several treatments that can help the patient manage bipolar disorder symptoms. This includes medications, counseling, and lifestyle changes. Some natural remedies have also been found to be beneficial for the patients. Treatment is directed at managing symptoms, which may include medications, Psychotherapy, Electroconvulsive therapy, and Transcranial magnetic stimulation.
The medications involved may be mood stabilizers, such as lithium (Lithobid), antipsychotics such as olanzapine (Zyprexa), antidepressants-antipsychotics such as fluoxetine-olanzapine (Symbyax), benzodiazepines, a type of anti-anxiety medication used for short-term treatment.
To improve the treatment scenario, several major pharma and biotech companies are developing therapies for Bipolar Disorder. Currently, Vanda Pharmaceuticals is leading the therapeutics market with its Bipolar Disorder drug candidates in the most advanced stage of clinical development.
Bipolar Disorder Companies Actively Working in the Therapeutics Market Include
-
Vanda Pharmaceuticals
-
Reviva Pharmaceuticals
-
SK BIOPHARMACEUTICALS
-
Pear Therapeutics
-
Arvelle Therapeutics
-
Janssen Research & Development
-
Sunovion Pharmaceuticals
-
Lyndra Therapeutics
-
ILTOO Pharma
-
COMPASS Pathways
-
NRx Pharmaceuticals
-
Carlsson Research AB
-
Sunovion
-
SAGE Therapeutics
-
Alzamend Neuro
-
OWP Pharmaceuticals
-
Entheogenix Biosciences
And many others
Emerging and Marketed Bipolar Disorder Therapies Covered in the Report Include:
-
Iloperidone: Vanda Pharmaceuticals
-
RP5063: Reviva Pharmaceuticals
-
Caplyta, also known as Lumateperone: Intra-Cellular Therapies
-
NRX-100/NRX-101: NeuroRx
-
SEP-4199: Sunovion (Sumitomo Dainippon Pharma)
-
Rexulti/Rxulti, also known as Brexpiprazole: Lundbeck/Otsuka Pharmaceutical
-
COMP 360, also known as Psilocybin therapy: COMPASS Pathways
-
Falkieri: Celon Pharma
And many more
The Report Covers an In-depth Assessment of Emerging Drugs and key Companies. Download the Sample Report to Learn More @
https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market-insight
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Bipolar Disorder Competitive Intelligence Analysis
4. Bipolar Disorder Market Overview at a Glance
5. Bipolar Disorder Disease Background and Overview
6. Bipolar Disorder Patient Journey
7. Bipolar Disorder Patient Population and Epidemiology Trends (In the US, EU5, and Japan)
8. Bipolar Disorder Treatment Algorithm, Current Treatment, and Medical Practices
9. Bipolar Disorder Unmet Needs
10. Key Endpoints of Bipolar Disorder Treatment
11. Bipolar Disorder Marketed Therapies
12. Bipolar Disorder Emerging Drugs and Latest Therapeutic Advances
13. Bipolar Disorder Seven Major Market Analysis
14. Attribute Analysis
15. Bipolar Disorder Market Outlook (In US, EU5, and Japan)
16. Bipolar Disorder Companies Active in the Market
17. Bipolar Disorder Access and Reimbursement Overview
18. KOL Views on the Bipolar Disorder Market
19. Bipolar Disorder Market Drivers
20. Bipolar Disorder Market Barriers
21. Appendix
22. DelveInsight Capabilities
23. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download the Sample PDF to Learn More About the Key Offerings of the Report @
https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market-insight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Other Trending Healthcare Reports by DelveInsight
“Cerebral Infarction Market Insights, Epidemiology, and Market Forecast-2032” report deliver an in-depth understanding of the historical and forecasted epidemiology as well as the Cerebral Infarction market size, share, trends, and growth analysis in the seven major markets (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. Moreover, it also covers the current treatment practices, emerging drugs, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the Cerebral Infarction market.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/market-research